JAGWINDER SANDHU: Open Payments
NPI 1821187691 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 32 payments from 6 companies in 2025. Trend: 2023 $459 · 2024 $552 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $191 |
| Teva Pharmaceuticals USA, Inc. | 7 | $123 |
| Otsuka America Pharmaceutical, Inc. | 7 | $120 |
| Lundbeck LLC | 6 | $115 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Alkermes, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY, ARISTADA.
Industry payments across NJ — which companies pay providers there.
